Genvor Incorporated
GNVR
$0.60
-$0.02-3.07%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -75.90% | 122.77% | 60.27% | 86.98% | 151.08% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -69.50% | 130.32% | 64.88% | 86.33% | 146.19% |
| Operating Income | 69.50% | -130.32% | -64.88% | -86.33% | -146.19% |
| Income Before Tax | 82.19% | -93.73% | -53.46% | -76.72% | -126.97% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 82.19% | -93.73% | -53.46% | -76.72% | -126.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 82.19% | -93.73% | -53.46% | -76.72% | -126.97% |
| EBIT | 69.50% | -130.32% | -64.88% | -86.33% | -146.19% |
| EBITDA | 69.51% | -130.42% | -64.91% | -86.39% | -146.31% |
| EPS Basic | 87.34% | -80.63% | -40.45% | -63.33% | -110.84% |
| Normalized Basic EPS | 78.07% | -106.17% | -49.31% | -73.95% | -127.21% |
| EPS Diluted | 87.34% | -80.63% | -40.45% | -63.33% | -110.84% |
| Normalized Diluted EPS | 78.07% | -106.17% | -49.31% | -73.95% | -127.21% |
| Average Basic Shares Outstanding | 42.24% | 29.26% | 19.46% | 12.65% | 7.61% |
| Average Diluted Shares Outstanding | 42.24% | 29.26% | 19.46% | 12.65% | 7.61% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |